| Resistance to targeted therapy in renal-cell carcinoma - Abstract - UroToday |
|
|
UroToday... mammalian target of rapamycin (mtor), has produced robust clinical effects and revolutionised the treatment of metastatic renal-cell carcinoma (RCC). ... read more |